GCB-002

N/A

Report date: 2025/04/07 13:23:11

Base Information

Drug NameGCB-002
Drug Alias NameGCB-002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionMethyl-CpG-binding protein 2 modulators
TargetsMethyl-CpG-binding protein 2
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jinke Bo Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jinke Bo Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A